Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.

The closing price of Celestica, Inc (NYSE: CLS) was $244.08 for the day, down -0.10% from the previous closing price of $244.33. In other words, the price has decreased by -$0.10 from its previous closing price. On the day, 3.11 million shares were traded. CLS stock price reached its highest trading level at $250.1499 during the session, while it also had its lowest trading level at $239.02.

Ratios:

Our analysis of CLS’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 89.47 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 72.97. For the most recent quarter (mrq), Quick Ratio is recorded 0.86 and its Current Ratio is at 1.44. In the meantime, Its Debt-to-Equity ratio is 0.58 whereas as Long-Term Debt/Eq ratio is at 0.55.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Citigroup on July 21, 2025, initiated with a Neutral rating and assigned the stock a target price of $172.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on May 30 ’25 when Agrawal Alok K. bought 3,672 shares for $119.47 per share.

Laurette Koellner bought 100,000 shares of CLS for $8,269,000 on Mar 31 ’25. On Mar 19 ’25, another insider, Laurette T Koellner, who serves as the Director of the company, bought 151,717 shares for $91.92 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CLS now has a Market Capitalization of 28193925120 and an Enterprise Value of 28776478720. As of this moment, Celestica,’s Price-to-Earnings (P/E) ratio for their current fiscal year is 53.02, and their Forward P/E ratio for the next fiscal year is 36.28. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.94. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.65 while its Price-to-Book (P/B) ratio in mrq is 15.97. Its current Enterprise Value per Revenue stands at 2.718 whereas that against EBITDA is 31.279.

Stock Price History:

The Beta on a monthly basis for CLS is 1.85, which has changed by 4.3857017 over the last 52 weeks, in comparison to a change of 0.1725707 over the same period for the S&P500. Over the past 52 weeks, CLS has reached a high of $257.40, while it has fallen to a 52-week low of $41.74. The 50-Day Moving Average of the stock is 30.82%, while the 200-Day Moving Average is calculated to be 96.96%.

Shares Statistics:

CLS traded an average of 3.63M shares per day over the past three months and 3740560 shares per day over the past ten days. A total of 115.00M shares are outstanding, with a floating share count of 114.44M. Insiders hold about 0.51% of the company’s shares, while institutions hold 74.41% stake in the company. Shares short for CLS as of 1755216000 were 5948533 with a Short Ratio of 1.64, compared to 1752537600 on 4443317. Therefore, it implies a Short% of Shares Outstanding of 5948533 and a Short% of Float of 5.1999997.

Earnings Estimates

Its stock is currently analyzed by 12.0 different market analysts. The consensus estimate for the next quarter is $1.49, with high estimates of $1.55 and low estimates of $1.38.

Analysts are recommending an EPS of between $5.89 and $5.45 for the fiscal current year, implying an average EPS of $5.57. EPS for the following year is $6.73, with 14.0 analysts recommending between $7.59 and $6.35.

Revenue Estimates

It is expected that $90B in revenue will be generated in the current quarter, according to 11 analysts. It ranges from a high estimate of $3.09B to a low estimate of $2.99B. As of the current estimate, Celestica, Inc’s year-ago sales were $2.5BFor the next quarter, 11 analysts are estimating revenue of $3.05B. There is a high estimate of $3.15B for the next quarter, whereas the lowest estimate is $2.82B.

A total of 13 analysts have provided revenue estimates for CLS’s current fiscal year. The highest revenue estimate was $12.12B, while the lowest revenue estimate was $11.38B, resulting in an average revenue estimate of $11.64B. In the same quarter a year ago, actual revenue was $9.65BBased on 13 analysts’ estimates, the company’s revenue will be $13.62B in the next fiscal year. The high estimate is $14.02B and the low estimate is $13.3B.